Abstract
Transgenic mouse models were established to study tumorigenesis of bronchiolo-alveolar adenocarcinomas derived from alveolar type II pneumocytes (AT-II cells). Transgenic lines expressing the murine oncogene c-myc under the control of the lung-specific surfactant protein C promoter developed multifocal bronchiolo-alveolar hyperplasias, adenomas and carcinomas respectively, whereas transgenic lines expressing a secretable form of the epidermal growth factor (IgEGF), a structural and functional homologue of transforming growth factor α (TGFα), developed hyperplasias of the alveolar epithelium. Since the oncogenes c-myc and TGFα are frequently overexpressed in human lung bronchiolo-alveolar adenocarcinomas, these mouse lines are useful as models for human lung bronchiolo-alveolar adenocarcinomas. The average life expectancies of hemizygous and homozygous c-myc transgenics were 14.25 months and 9.2 months, respectively, suggesting that a dosage effect of c-myc caused an accelerated bronchiolo-alveolar adenocarcinoma formation. First analyses of double transgenics, hemizygous for both c-myc and IgEGF, show that these mice develop bronchiolo-alveolar adenocarcinomas at the average age of 9 months, indicating that these oncogenes cooperate during the lung cancer formation. Our results demonstrate that c-myc and EGF are directly involved and cooperate with one another during formation of bronchiolo-alveolar adenocarcinomas in the lung. © 2001 Cancer Research Campaign
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Alimandi M, Wang LM, Bottaro D, Lee CC, Kuo A, Frankel M, Fedi P, Tang C, Lippman M and Pierce JH (1997) Epidermal growth factor and betacellulin mediate signal transduction through co-expressed ErbB2 and ErbB3 receptors. EMBO J 15: 5608–5617
Battista P, Pizzicannella G, Vitullo P, Palmirotta R and Mariani-Costantini R (1993) The epidermal growth factor family in pulmonary carcinoids: immunohistochemical evidence of growth-promoting circuits. Mod Pathol 6: 162–166
Broers JL, Viallet J, Jensen SM, Pas H, Travis WD, Minna JD and Linnoila RI (1993) Expression of c-myc in progenitor cells of the bronchopulmonary epithelium and in a large number of non-small cell lung cancers. Am J Respir Cell Mol Biol 9: 33–43
Dalemans W, Perraud F, Le-Meur M, Gerlinger P, Courtney M and Pavirani A (1990) Heterologous protein expression by transimmortalized differentiated liver cell lines derived from transgenic mice. Biologicals 18: 191–198
Donaldson JC, Kaminsky DB and Elliott RC (1978) Bronchiolar carcinoma. Report of 11 cases and review of the literatur. Cancer 41: 250–258
Facchini LM and Penn LZ (1998) The molecular role of Myc in growth and transformation: recent discoveries lead to new insights. FASEB J 12: 633–651
Hardie WD, Bruno MD, Huelsman KM, Iwamoto HS, Carrigan PE, Leikauf GD, Whitsett JA and Korfhagen TR (1997) Postnatal lung function and morphology in transgenic mice expressing transforming growth factor-alpha. Am J Pathol 151: 1075–1083
Hogan B, Beddingtin R, Costantini F and Lacy E (1994). Manipulating the Mouse Embryo: A Laboratory Manual, Cold Spring Harbor, NY, Cold Spring Harbor Laboratory
Korfhagen TR, Bruno MD, Glasser SW, Ciraolo PJ, Whitsett JA, Lattier DL, Wikenheiser KA and Clark JC (1992) Murine pulmonary surfactant SP-A gene: cloning, sequence, and transcriptional activity. Am J Physiol 263: 546–554
Linnoila RI, Mulshine JL, Steinberg SM and Gazdar AF (1992) Expression of surfactant-associated protein in non-small-cell lung cancer: a discriminant between biologic subsets. J Natl Cancer Inst Monogr 13: 61–66
Lorenz J, Friedberg T, Paulus R, Oesch F and Ferlinz R (1994) Oncogene overexpression in non-small-cell lung cancer tissue: prevalence and clinicopathological significance. Clin Investig 72: 156–163
Marchetti A, Doglioni C, Barbareschi M, Buttitta F, Pellegrini S, Gaeta P, La Rocca R, Merlo G, Chella A, Angeletti CA, Dalla Palma P and Bevilacqua G (1998) Cyclin D1 and retinoblastoma susceptibility gene alterations in non-small cell lung cancer. Int J Cancer 75: 187–192
Minna JD, Hippins GA and Glatstein EJ (1989). In: De Vita VT Jr, Hellman S, Rosenburg SA (eds) Cancer: Principles and Practice of oncology, Lippincott: Philadelphia pp. 507–599
Moody TW (1996) Peptides and growth factors in non-small cell lung cancers. Peptides 17: 545–555
Perez-Stable C, Altmann NH, Mehta PP, Deftos LJ and Roos BA (1997) Prostate cancer progression, metstasis, and gene expression in transgenic mice. Cancer Res 57: 900–906
Ramljak D, Jones AB, Diwan BA, Perantoni AO, Hochadel JF and Anderson LM (1998) Epidermal growth factor and transforming growth factor- alpha-associated overexpression of cyclin D1, Cdk4, and c-Myc during hepatocarcinogenesis in Helicobacter hepaticus -infected A/JCr mice. Cancer Res 116: 276–280
Ravitz MJ, Yan S, Dolce C, Kinniburgh AJ and Wenner CE (1996) Differential regulation of p27 and cyclin D1 by TGF-beta and EGF in C3H 10T1/2 mouse fibroblasts. J Cell Physiol 168: 510–520
Rittinghausen S, Kaspareit J and Mohr U (1997) Incidence and spectrum of spontaneous neoplasms in Han: NMRI mice of both sexes. Exp Toxicol Pathol 49: 347
Sandgren EP, Luetteke NC, Qiu TH, Palmiter RD and Brinster RL (1993) Transforming growth factor alpha dramatically enhances oncogene induced carcinogenesis in transgenic mouse pancreas and liver. Mol Cell Biol 13: 320–330
Strayer MS, Guttantag SH and Ballard PL (1998) Targeting type II and Clara cells for adenovirus-mediated gene transfer using the surfactant protein B promoter. Am J Respir Cell Mol Biol 18: 1–11
Szabo E, Riffe ME, Steinberg SM, Birrer MJ and Linnoila RI (1996) Altered cJUN expression: An early event in human lung carcinogenesis. Cancer Res 52: 305–315
Tateishi M, Ishida T, Mitsudomi T, Kaneko S and Sugimachi K (1990) Immunohistochemical evidence of autocrine growth factors in adenocarcinoma of the human lung. Cancer Res 50: 7077–7080
Tönjes RR, Lohler J, O’Sullivan JF, Kay GF, Schmidt GH, Dalemans W, Pavirani A and Paul D (1995) Autocrine mitogen IgEGF cooperates with c-myc or with the Hcs locus during hepatocarcinogenesis in transgenic mice. Oncogene 10: 765–768
Tuveson DA and Jacks T (1999) Modeling human lung cancer in mice: similarities and shortcomings. Oncogene 18: 5318–5324
Wang LM, Kuo A, Alimandi M, Veri MC, Lee CC, Kapoor V, Ellmore N, Chen XH and Pierce JH (1998) ErbB2 expression increases the spectrum and potency of ligand-mediated signal transduction through ErbB4. Proc Natl Acad Sci 95: 6809–6814
Weaver TE and Whitsett JA (1991) Function and regulation of expression of pulmonary surfactant-associated proteins. Biochem J 273: 249–264
Wikenheiser KA, Clark JC, Linnoila RI, Stahlmann MT and Whitsett JA (1992) Simian virus 40 large T antigen directed by transcriptional elements of the human surfactant protein C gene produces pulmonary adenocarcinomas in transgenic mice. Cancer Res 52: 5342–5352
Yeh J and Yeh YC (1989) Transforming growth factor-alpha and human cancer. Biomed Pharmacother 43: 651–659
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Ehrhardt, A., Bartels, T., Geick, A. et al. Development of pulmonary bronchiolo-alveolar adenocarcinomas in transgenic mice overexpressing murine c-myc and epidermal growth factor in alveolar type II pneumocytes. Br J Cancer 84, 813–818 (2001). https://doi.org/10.1054/bjoc.2000.1676
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1054/bjoc.2000.1676
Keywords
This article is cited by
-
In vitro antiproliferative activity of Parrotia persica exclusive gallotannin
Medicinal Chemistry Research (2023)
-
Lineage-restricted neoplasia driven by Myc defaults to small cell lung cancer when combined with loss of p53 and Rb in the airway epithelium
Oncogene (2022)
-
In vivo screening identifies GATAD2B as a metastasis driver in KRAS-driven lung cancer
Nature Communications (2018)
-
TIP30 loss enhances cytoplasmic and nuclear EGFR signaling and promotes lung adenocarcinogenesis in mice
Oncogene (2013)
-
Lungenkrebs: vom Gen zur Therapie
Onkopipeline (2010)
